Scholarlink

<p>Delayed onset lactogenesis II has adverse effects on breastfeeding and neonatal health. This study aimed to determine the risk factors of DOL II, develop a predictive model for DOL II, and test its validity. This was a retrospective cohort study. A total of 450 pregnant women were involved in this study, including 112 cases with DOL II and 338 cases without DOL II, who were hospitalized between October 2023 and April 2024. Univariate and multivariate logistic regression analyses were conducted to determine the risk factors of DOL II, which were then included in the nomogram. The performance of the nomogram model was evaluated by the area under the receiver operating curve, calibration curve, and Hosmer–Lemeshow test. Decision curve analysis was used to evaluate the clinical efficacy of the nomogram. The results showed that maternal age, pre-pregnancy BMI, gestational age, parity, delivery mode, length of stage II labor, gestational diabetes, EPDS, maternal-infant separation, breastfeeding education during pregnancy, formula use, and onset of breastfeeding within the first hour were independent risk factors. In the derivation cohort, the AUC was 0.786. Youden index was 1.526, with a sensitivity of 0.781 and a specificity of 0.745. In the verification cohort, AUC was 0.748. The nomogram model has good consistency and performance, which can identify women who are at high risk of DOL II.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Development and validation of a model for predicting the risks for delayed onset of lactogenesis stage II for Chinese pregnant women

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年5月16日

查看全文
  • Wenting Li,
  • Guofang Kuang,
  • Yanqiu Chen,
  • Peng Yu,
  • Meng Zhang

摘要

Delayed onset lactogenesis II has adverse effects on breastfeeding and neonatal health. This study aimed to determine the risk factors of DOL II, develop a predictive model for DOL II, and test its validity. This was a retrospective cohort study. A total of 450 pregnant women were involved in this study, including 112 cases with DOL II and 338 cases without DOL II, who were hospitalized between October 2023 and April 2024. Univariate and multivariate logistic regression analyses were conducted to determine the risk factors of DOL II, which were then included in the nomogram. The performance of the nomogram model was evaluated by the area under the receiver operating curve, calibration curve, and Hosmer–Lemeshow test. Decision curve analysis was used to evaluate the clinical efficacy of the nomogram. The results showed that maternal age, pre-pregnancy BMI, gestational age, parity, delivery mode, length of stage II labor, gestational diabetes, EPDS, maternal-infant separation, breastfeeding education during pregnancy, formula use, and onset of breastfeeding within the first hour were independent risk factors. In the derivation cohort, the AUC was 0.786. Youden index was 1.526, with a sensitivity of 0.781 and a specificity of 0.745. In the verification cohort, AUC was 0.748. The nomogram model has good consistency and performance, which can identify women who are at high risk of DOL II.